Related Experiment Video
Updated: Oct 7, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Host Immune Responses to Clostridioides difficile: Toxins and Beyond
Britt Nibbering1,2, Dale N Gerding3, Ed J Kuijper1,2
1Center for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, Netherlands.
Clostridioides difficile infection (CDI) is a major cause of hospital-acquired diarrhea. This review compares immune responses to toxigenic and non-toxigenic C. difficile, highlighting non-toxin proteins as a potential therapeutic target.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Clostridioides difficile infection (CDI) is a significant cause of nosocomial diarrhea, often resistant to antibiotics.
- Toxin production is the primary virulence mechanism in CDI.
- Treatment failures and recurrence necessitate novel therapeutic strategies.
Purpose of the Study:
- To comprehensively describe and compare host immune responses to toxigenic and non-toxigenic C. difficile.
- To evaluate the role of non-toxin proteins in immune responses.
- To explore the potential of non-toxigenic strains and non-toxin-based immunization for CDI prevention and treatment.
Main Methods:
- Review of existing literature on immune responses to C. difficile.
- Comparison of immune responses to toxigenic C. difficile and non-toxigenic C. difficile (focusing on non-toxin proteins).
- Evaluation of toxin-based and non-toxin-based immunization studies.
Main Results:
- Similarities observed in host immune responses to toxigenic and non-toxigenic C. difficile, including granulocyte influx and T-cell responses.
- Differences in immune responses may indicate genuine variations or knowledge gaps regarding non-toxigenic C. difficile.
- Plasma cells play a crucial role in protection against CDI, as indicated by immunization studies.
Conclusions:
- Immune responses to non-toxin proteins of C. difficile warrant further investigation.
- Non-toxigenic C. difficile strains and non-toxin-based approaches show promise for future CDI therapies.
- Focusing research on non-toxin proteins is vital given the limited success of toxin-based interventions.
Related Concept Videos
Cell-mediated Immune Responses
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

